These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9048835)

  • 21. [Thymidylate synthase expression in patients with hypopharyngeal carcinoma].
    Yamaoka H; Tsukuda M; Mochimatsu I; Nagahara T; Enomoto H; Kagata H; Kagesato Y; Daicho S; Mizuno H; Nishimura G; Baba Y; Kawakami K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1007-12. PubMed ID: 9644315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients.
    Paradiso A; Xu J; Mangia A; Chiriatti A; Simone G; Zito A; Montemurro S; Giuliani F; Maiello E; Colucci G
    Int J Cancer; 2004 Aug; 111(2):252-8. PubMed ID: 15197779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
    Vokes EE; Schilsky RL; Weichselbaum RR; Kozloff MF; Panje WR
    J Clin Oncol; 1990 Feb; 8(2):241-7. PubMed ID: 1688926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
    Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
    Etienne MC; Chéradame S; Fischel JL; Formento P; Dassonville O; Renée N; Schneider M; Thyss A; Demard F; Milano G
    J Clin Oncol; 1995 Jul; 13(7):1663-70. PubMed ID: 7602356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic importance of thymidylate synthase expression in early breast cancer.
    Pestalozzi BC; Peterson HF; Gelber RD; Goldhirsch A; Gusterson BA; Trihia H; Lindtner J; Cortés-Funes H; Simmoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Allegra CJ; Johnston PG
    J Clin Oncol; 1997 May; 15(5):1923-31. PubMed ID: 9164203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.
    Westra JL; Hollema H; Schaapveld M; Platteel I; Oien KA; Keith WN; Mauritz R; Peters GJ; Buys CH; Hofstra RM; Plukker JT
    Ann Oncol; 2005 Oct; 16(10):1646-53. PubMed ID: 16012177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A complete response after neoadjuvant chemotherapy for advanced gastric cancer with esophageal invasion].
    Yabusaki H; Nashimoto A; Tanaka O
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):119-23. PubMed ID: 11816467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
    Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
    Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.
    Schrijvers D; Johnson J; Jiminez U; Gore M; Kosmidis P; Szpirglas H; Robbins K; Oliveira J; Lewensohn R; Schüller J; Riviere A; Arvay C; Langecker P; Jacob H; Cvitkovic E; Vokes E
    J Clin Oncol; 1998 Mar; 16(3):1054-9. PubMed ID: 9508190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
    Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
    J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy.
    Krug S; Boch M; Nimphius W; Gress TM; Michl P; Rinke A
    Pancreatology; 2017; 17(1):139-145. PubMed ID: 28027897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
    Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
    Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy.
    Yeh CN; Jung SM; Chen TW; Hwang TL; Jan YY; Chen MF
    Langenbecks Arch Surg; 2010 Mar; 395(3):217-25. PubMed ID: 20012317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.